Éruption cutanée d’origine médicamenteuse associée à l’empagliflozine

Kevin Yau; Stephanie Poon; Bourne L. Auguste

doi:10.1503/cmaj.220934-f

Article Information

vol. 195 no. 11 E430-E431

DOI

https://doi.org/10.1503/cmaj.220934-f

PubMed

37072234

History

Published online March 19, 2023.

© 2023 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

Author Information

Kevin Yau, MD,
Stephanie Poon, MD MSc,
Bourne L. Auguste, MD MSc

Divisions de néphrologie (Yau, Auguste) et de cardiologie (Poon), département de médecine, Centre des sciences de la santé Sunnybrook, Faculté de médecine Temerty, Université de Toronto, Toronto, Ont.